Xudong Hu

925 total citations
69 papers, 660 citations indexed

About

Xudong Hu is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Xudong Hu has authored 69 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 18 papers in Radiology, Nuclear Medicine and Imaging and 17 papers in Oncology. Recurrent topics in Xudong Hu's work include Medical Imaging Techniques and Applications (9 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Xudong Hu is often cited by papers focused on Medical Imaging Techniques and Applications (9 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Xudong Hu collaborates with scholars based in China, United States and United Kingdom. Xudong Hu's co-authors include Shuanghu Yuan, Jinming Yu, Wanhu Li, Shuzhen Wang, Li Ma, Hong Cao, Wei Zhao, Song Gao, Jinbo Yue and Shuqiang Zhao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xudong Hu

65 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xudong Hu China 16 226 183 158 122 116 69 660
Bo‐Hyun Moon United States 12 155 0.7× 295 1.6× 94 0.6× 91 0.7× 72 0.6× 27 510
Ognoon Mungunsukh United States 15 143 0.6× 228 1.2× 106 0.7× 63 0.5× 51 0.4× 25 596
Georges Tarlet France 16 281 1.2× 334 1.8× 217 1.4× 164 1.3× 129 1.1× 29 722
Christine Sikora United States 8 327 1.4× 302 1.7× 201 1.3× 78 0.6× 76 0.7× 9 669
Gabriel Krigsfeld United States 14 174 0.8× 340 1.9× 129 0.8× 88 0.7× 159 1.4× 19 692
Ye Tian China 18 117 0.5× 382 2.1× 229 1.4× 246 2.0× 191 1.6× 79 867
Kerstin Müller Germany 15 215 1.0× 237 1.3× 74 0.5× 100 0.8× 115 1.0× 25 717
Ming Yu China 15 142 0.6× 279 1.5× 73 0.5× 193 1.6× 192 1.7× 54 644
Lue Sun Japan 13 170 0.8× 208 1.1× 190 1.2× 77 0.6× 80 0.7× 33 510
Richard B. Richardson Canada 14 195 0.9× 176 1.0× 115 0.7× 71 0.6× 70 0.6× 42 569

Countries citing papers authored by Xudong Hu

Since Specialization
Citations

This map shows the geographic impact of Xudong Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xudong Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xudong Hu more than expected).

Fields of papers citing papers by Xudong Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xudong Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xudong Hu. The network helps show where Xudong Hu may publish in the future.

Co-authorship network of co-authors of Xudong Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xudong Hu. A scholar is included among the top collaborators of Xudong Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xudong Hu. Xudong Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Lansheng, Duo Xu, Xudong Hu, et al.. (2025). Cascade reaction–driven biomimetic scintillant/metal–organic frameworks for X-ray triggered combinational therapy against glioma. Materials Today Bio. 33. 102069–102069. 1 indexed citations
2.
Hu, Xudong, et al.. (2024). High-resolution, high-speed and low-cost flexible tactile sensor array system. Measurement. 241. 115630–115630. 3 indexed citations
3.
Xue, Junli, Yan Zhang, Xudong Hu, et al.. (2024). Phase I/II safety and preliminary efficacy of PM1022, a bispecific antibody targeting PD-L1 and TIGIT, in patients with advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). e14694–e14694. 2 indexed citations
4.
Li, Yueshuo, Longlong Xie, Feng Shi, et al.. (2024). CYLD induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity in nasopharyngeal carcinoma. Cell Death and Disease. 15(1). 95–95. 7 indexed citations
5.
Wang, Xiaodong, Zhao Lv, Xudong Hu, et al.. (2024). Comparative Transcriptomics Analysis Reveals Unique Immune Response to Grass Carp Reovirus Infection in Barbel Chub (Squaliobarbus curriculus). Biology. 13(4). 214–214. 5 indexed citations
6.
Lu, Wen-Jie, et al.. (2023). Risk factors analysis and risk prediction model construction of non-specific low back pain: an ambidirectional cohort study. Journal of Orthopaedic Surgery and Research. 18(1). 545–545. 5 indexed citations
7.
Zhang, Xiqin, et al.. (2023). The prognostic value of 11th Japanese classification and 8th AJCC staging systems in Chinese patients with esophageal squamous cell carcinoma. Journal of Cardiothoracic Surgery. 18(1). 251–251. 1 indexed citations
8.
Hu, Xudong, et al.. (2022). Dezocine Has the Potential to Regulate the Clinical and Biological Features of Tumors. Drug Design Development and Therapy. Volume 16. 1121–1129. 5 indexed citations
9.
Hu, Xudong, Haorong Li, Zhongkai Wang, et al.. (2022). Genomic deciphering of sex determination and unique immune system of a potential model species rare minnow ( Gobiocypris rarus ). Science Advances. 8(5). eabl7253–eabl7253. 15 indexed citations
10.
Hu, Xudong, Bing Luo, Qing Wu, et al.. (2021). Effects of Dezocine and Sufentanil on Th1/Th2 Balance in Breast Cancer Patients Undergoing Surgery. Drug Design Development and Therapy. Volume 15. 4925–4938. 10 indexed citations
11.
Wang, Shou‐Mei, Peiwei Yang, Xiaojun Feng, et al.. (2021). Apigenin Inhibits the Growth of Hepatocellular Carcinoma Cells by Affecting the Expression of microRNA Transcriptome. Frontiers in Oncology. 11. 657665–657665. 38 indexed citations
12.
Shi, Lixia, Xudong Hu, Dacong Yin, et al.. (2020). Acute toxic effects of lead (Pb2+) exposure to rare minnow (Gobiocypris rarus) revealed by histopathological examination and transcriptome analysis. Environmental Toxicology and Pharmacology. 78. 103385–103385. 29 indexed citations
13.
14.
Liu, Cheng, M. Zhang, Bo Sun, et al.. (2020). Single-cell RNA-seq Reveals Chemoradiotherapy-induced Immune Microenvironment Modulation in Locally Advanced Cervical Cancer. International Journal of Radiation Oncology*Biology*Physics. 108(3). S93–S93. 1 indexed citations
15.
16.
Yuan, Shuanghu, Yinping Dong, Yong Huang, et al.. (2018). Relationship Between Clinicopathological Characteristics and PET/CT Uptakes in Esophageal Squamous Cell Carcinoma Patients: 18F-Alfatide Versus 18F-FDG. International Journal of Radiation Oncology*Biology*Physics. 102(3). S195–S195. 1 indexed citations
17.
18.
Zhang, Peng, Xudong Hu, Jinbo Yue, et al.. (2015). Early detection of radiation-induced heart disease using 99mTc-MIBI SPECT gated myocardial perfusion imaging in patients with oesophageal cancer during radiotherapy. Radiotherapy and Oncology. 115(2). 171–178. 28 indexed citations
19.
Hu, Xudong, Ligang Xing, Yang Jiao, et al.. (2012). BTG2 Overexpression Increases the Radiosensitivity of Breast Cancer Cells In Vitro and In Vivo. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 20(10). 457–465. 18 indexed citations
20.
Hu, Xudong, et al.. (2001). Effect of Retarding Aging Chinese Drug Bushen Yijing Decoction on Rat Left Ventricular Myosin Heavy Chain(MHC) mRNA Change with Aging. Zhongguo zhongyi jichu yixue zazhi. 7(4). 34–36. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bo‐Hyun Moon Breakdown of academic impact, for papers by Ognoon Mungunsukh Breakdown of academic impact, for papers by Georges Tarlet Breakdown of academic impact, for papers by Christine Sikora Breakdown of academic impact, for papers by Gabriel Krigsfeld Breakdown of academic impact, for papers by Ye Tian Breakdown of academic impact, for papers by Kerstin Müller Breakdown of academic impact, for papers by Ming Yu Breakdown of academic impact, for papers by Lue Sun Breakdown of academic impact, for papers by Richard B. Richardson
Rankless by CCL
2026